These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1987902)

  • 1. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
    Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
    Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of serum thymidine kinase in children with acute leukemia.
    Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
    Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum deoxythymidine kinase in adult T-cell leukemia and its related disorders].
    Sadamori N; Yamaguchi K; Ikeda S; Hakariya S; Mine M; Itoyama T; Iwasaki H; Kinoshita H; Hayashi K; Ichimaru M
    Rinsho Ketsueki; 1990 Nov; 31(11):1812-7. PubMed ID: 2287066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum deoxythymidine kinase in hematological malignancy].
    Naito K; Yamada K
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia].
    Aulbert E; Fromm H; Hornemann H
    Med Klin (Munich); 1991 Jun; 86(6):297-304. PubMed ID: 1886510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in-house assay for serum deoxythymidine kinase.
    Seah LH; Ton SH; Cheong SK; Hamidah NH
    Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of thymidine kinase in colorectal and breast cancer.
    Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases.
    Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A
    J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridization.
    Evinger-Hodges MJ; Spinolo JA; Spencer V; Nieto P; Dicke KA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():13-5. PubMed ID: 2653488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of the determination of lactate dehydrogenase in acute leukemia and non-Hodgkin's lymphoma].
    D'Angelo G; Giardini C; Calvano D
    Minerva Med; 1989 Jun; 80(6):549-52. PubMed ID: 2747983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells in patients with acute myeloid leukemia.
    Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
    Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and cytokinetic characterization of leukemic cells: prediction of treatment results and early diagnosis of relapse.
    Wilmanns W; Sauer H; Pelka-Fleischer R; Twardzik L; Vehling-Kaiser U
    Prog Clin Biol Res; 1988; 276():237-54. PubMed ID: 3174679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.